Sales from the company’s medical device business increased 6.4 percent in the second quarter, reaching a total of $1.37 billion. Net sales rose by 3.2 percent to $5.33 billion, surpassing Wall Street’s prediction of $5.24 billion.
Abbott’s medical device division produces products for heart, diabetes and eye patients.
Recently, Abbott shared a definitive agreement to acquire St. Paul, Minn.-based device company St. Jude Medical for $25 billion. The deal is expected to close by the end of the year.
More articles on medical devices:
This headband isn’t for fashion— it offers migraine relief
Zimmer Biomet acquires Medtech SA
FDA approves Syneron Candela’s weight loss device
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
